Medilabo Rfp, Inc
Medilabo RFP, Inc, headquartered in Japan with a US office in Boston, is a clinical-stage biopharmaceutical company focused on developing repurposed small molecules-based treatments to restore neuronal function and slow neurodegeneration. Medilabo aims to halt the progression of cognitive impairment and reverse the course of neurological diseases with its novel multi-modal mechanisms of action. Medilabo is currently advancing its lead candidates, ML1707 and ML1808, the novel approaches of repurposed small molecules for Alzheimer’s, Parkinson’s disease, Dementia with Lewy bodies, Frontotemporal Dementia and ALS.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Medilabo Rfp, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Medilabo Rfp, Inc
2 distinct titles indexed · top 2 shown.
- 1chief executive officer
- 1pharmaceutical physician
Sign up to unlock all 2 contacts at Medilabo Rfp, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Medilabo Rfp, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.